INS and type 2 diabetes mellitus: Chronic low‐grade inflammation is a hallmark of type 2 diabetes, leading to impaired β cell islet structure and function, inducing hepatic IR, and impairing glucose tolerance by blocking glucose‐stimulated insulin secretion (GSIS).